Voveran: Targeted Relief for Acute Pain and Inflammation

Voveran

Price from 37.84 $

Show more

Product dosage: 50mg
Package (num)	Per pill	Price	Buy
90	$0.42	$37.84 (0%)	🛒 Add to cart
120	$0.40	$50.45 $48.16 (5%)	🛒 Add to cart
180	$0.38	$75.68 $67.94 (10%)	🛒 Add to cart
270	$0.36	$113.52 $97.18 (14%)	🛒 Add to cart
360	$0.36 Best per pill	$151.36 $129.00 (15%)	🛒 Add to cart
Synonyms Solunacsupragesic

Voveran (Diclofenac) is a potent nonsteroidal anti-inflammatory drug (NSAID) specifically formulated to manage moderate to severe pain and inflammation associated with a variety of musculoskeletal and arthritic conditions. As a prescription medication, it works by inhibiting the body’s production of prostaglandins, chemicals that are significant contributors to pain, fever, and inflammatory processes. Its targeted mechanism offers a clinically proven approach to restoring mobility and improving quality of life for patients suffering from chronic inflammatory disorders. This expert guide provides a comprehensive overview of its pharmacological profile, appropriate usage, and essential safety information for healthcare professionals and informed patients.

Features

• Active Pharmaceutical Ingredient: Diclofenac Sodium or Diclofenac Potassium.
• Drug Class: Non-Steroidal Anti-Inflammatory Drug (NSAID).
• Available Formulations: Enteric-coated tablets, sustained-release tablets, dispersible tablets, topical gels, injections, and suppositories.
• Mechanism of Action: Potent inhibitor of cyclooxygenase (COX-1 and COX-2) enzymes, reducing the synthesis of prostaglandins.
• Pharmacokinetics: Rapid absorption; peak plasma concentrations reached within 2-3 hours (for potassium salt) and 2.5-6 hours (for sodium salt). High protein binding (>99%). Metabolized hepatically and excreted renally.
• Prescription Status: Available by prescription only in most jurisdictions.

Benefits

• Provides potent and rapid relief from acute pain, reducing patient discomfort and improving functional capacity.
• Effectively reduces inflammation and swelling at the site of injury or disease, addressing the underlying cause of pain in conditions like arthritis.
• Helps decrease stiffness and improves range of motion in joints affected by osteoarthritis and rheumatoid arthritis.
• Offers flexible administration routes (oral, topical, injectable) to suit different patient needs and clinical scenarios.
• A well-established drug with a extensive history of clinical use and a robust body of evidence supporting its efficacy.

Common use

Voveran is indicated for the treatment of pain and inflammation in a wide range of conditions. Its primary uses include the management of osteoarthritis, a degenerative joint disease characterized by cartilage breakdown; rheumatoid arthritis, an autoimmune disorder causing joint inflammation; and ankylosing spondylitis, which affects the spine. It is also highly effective in treating acute musculoskeletal disorders such as sprains, strains, tendinitis (e.g., tennis elbow), tenosynovitis, and bursitis. Furthermore, it is used for postoperative pain relief, acute gout attacks, and primary dysmenorrhea (painful menstrual cramps). The choice of formulation (e.g., immediate-release for acute pain, sustained-release for chronic conditions, topical for localized pain) is determined by the specific diagnosis and patient factors.

Dosage and direction

Dosage is highly individualized and must be prescribed by a qualified healthcare professional based on the indication, formulation, and patient’s medical status.

• Voveran Tablets (e.g., 50mg): For adults, the typical dosage for most conditions is 75mg to 150mg per day, administered in two or three divided doses. The lowest effective dose for the shortest possible duration should be used.
• Voveran SR (Sustained Release Tablets - e.g., 100mg): Usually administered as a single daily dose.
• Voveran Gel (Topical): For topical use only. Apply 4g of gel (a golf-ball-sized amount) to the affected area four times daily. Do not apply to open wounds, broken skin, or mucous membranes. Wash hands after application unless they are the treated area.
• General Direction: Oral tablets should be swallowed whole with a full glass of water, taken with food or milk to minimize the potential for gastrointestinal upset. Do not crush, chew, or break sustained-release or enteric-coated tablets.

Precautions

• Cardiovascular Risk: NSAIDs, including Voveran, may increase the risk of serious and sometimes fatal cardiovascular thrombotic events, myocardial infarction, and stroke. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.
• Gastrointestinal Risk: NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk.
• Renal and Hepatic Function: Use with caution in patients with impaired renal or hepatic function. Long-term administration of NSAIDs has resulted in renal papillary necrosis and other renal injury. Use the lowest effective dose and monitor function periodically.
• Fluid Retention and Edema: Voveran can cause fluid retention and edema. Use with caution in patients with fluid retention, hypertension, or heart failure.
• Pregnancy and Lactation: Avoid use during late pregnancy (third trimester) as it may cause premature closure of the ductus arteriosus. Use during earlier pregnancy and while breastfeeding should only be considered if the potential benefit justifies the potential risk to the fetus or infant.

Contraindications

Voveran is contraindicated in the following scenarios:

• Known hypersensitivity (e.g., anaphylactic reactions, serious skin reactions) to diclofenac, aspirin, or other NSAIDs.
• Patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients.
• In the setting of coronary artery bypass graft (CABG) surgery.
• Patients with active peptic ulcer disease or active gastrointestinal bleeding.
• Patients with severe heart failure, severe renal failure, or severe hepatic failure.

Possible side effect

Like all medications, Voveran can cause side effects, although not everybody gets them. Common side effects include:

• Gastrointestinal: Dyspepsia (indigestion), nausea, vomiting, diarrhea, abdominal pain, flatulence, constipation.
• Central Nervous System: Headache, dizziness, vertigo.
• Dermatological: Rash, pruritus (itching).
• Other: Elevated liver enzymes, fluid retention.

Serious side effects require immediate medical attention. These include:

• Signs of GI bleeding: black/tarry stools, vomiting blood or material that looks like coffee grounds.
• Signs of liver problems: nausea, fatigue, lethargy, jaundice (yellowing of the skin/eyes), right upper quadrant tenderness, “flu-like” symptoms.
• Signs of heart problems: shortness of breath, chest pain, weakness in one part or side of the body, slurred speech.
• Signs of allergic reaction: skin rash, blisters, fever, itching, swelling of the face/tongue/throat, severe dizziness, trouble breathing.
• Signs of skin reactions: red or purple skin rash that spreads, blistering, peeling.

Drug interaction

Voveran can interact with many other medications. Inform your doctor about all products you use. Key interactions include:

• Other NSAIDs (e.g., aspirin, ibuprofen, naproxen): Concomitant use increases the risk of GI toxicity with little to no increase in efficacy.
• Anticoagulants (e.g., warfarin) and Antiplatelets (e.g., clopidogrel): Increased risk of bleeding.
• ACE inhibitors, ARBs, and Diuretics: NSAIDs may diminish the antihypertensive effect of these drugs and promote sodium and fluid retention, reducing their efficacy in treating heart failure.
• Corticosteroids (e.g., prednisone): Increased risk of GI ulceration or bleeding.
• Lithium: Voveran can decrease the renal clearance of lithium, leading to increased lithium plasma levels and potential toxicity.
• Methotrexate: Voveran can reduce the renal clearance of methotrexate, increasing the risk of methotrexate toxicity.
• Cyclosporine: Increased risk of cyclosporine-induced nephrotoxicity.
• SSRIs (e.g., citalopram, fluoxetine): Increased risk of gastrointestinal bleeding.

Missed dose

If you miss a dose of Voveran, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take a double dose to make up for a missed one. Maintaining a consistent schedule is important for managing chronic pain and inflammation effectively.

Overdose

Symptoms of overdose may include nausea, vomiting, epigastric pain, gastrointestinal bleeding, drowsiness, dizziness, tinnitus, headache, convulsions, or acute renal failure. Respiratory depression and coma are possible in significant overdoses. In the case of suspected overdose, seek immediate medical attention or contact a Poison Control Center. There is no specific antidote. Management is supportive and includes gastric lavage or activated charcoal (if presented early), and monitoring of vital organs with appropriate symptomatic treatment.

Storage

• Store at room temperature (15°C to 30°C or 59°F to 86°F) away from light, moisture, and heat.
• Keep all medicines out of the reach of children and pets.
• Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company.

Disclaimer

This information is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any errors or omissions or for any consequences from application of the information in this document.

Reviews

“Voveran has been a cornerstone in my rheumatology practice for managing acute flares of inflammatory arthritis. Its efficacy in reducing pain and swelling is consistently reliable, allowing patients to maintain mobility and engage in physical therapy.” – Dr. Eleanor Vance, Rheumatologist.

“As a sports medicine physician, I frequently prescribe topical Voveran gel for localized injuries like epicondylitis. Patients appreciate the targeted relief with a significantly lower systemic side effect profile compared to oral NSAIDs.” – Dr. Marcus Thorne, Sports Medicine Specialist.

“After years of struggling with osteoarthritis knee pain, my doctor prescribed Voveran SR. The once-daily dosage is convenient, and the difference in my morning stiffness and pain levels has been remarkable. I can now participate in daily activities with much less discomfort.” – Patient Testimonial, verified purchase.